UBS Reiterates Aberdeen Group (SLFPF) Sell Recommendation

UBS reiterated a 'Sell' recommendation for Aberdeen Group (OTCPK:SLFPF) on October 17, 2025, despite an average analyst price target of $2.67/share, which suggests a 39.07% upside from its last closing price of $1.92. The company projects strong financial growth, with annual revenue expected to increase by 17.29% to $1,560MM and non-GAAP EPS at $0.12. Concurrently, institutional sentiment appears positive, with an increase in the number of funds holding positions, a 16.36% rise in average portfolio weight, and major holders like Vanguard and iShares significantly boosting their stakes.

Analysis

UBS reiterated a 'Sell' recommendation for Aberdeen Group (OTCPK:SLFPF) on October 17, 2025, despite an average one-year price target of $2.67/share, which implies a significant 39.07% upside from its last reported closing price of $1.92. This divergence highlights a potential discrepancy between a specific analyst's outlook and broader market expectations, as the price target range extends from $2.24 to $3.38.

Aberdeen Group projects robust financial growth, with annual revenue expected to increase by 17.29% to $1,560 million. The company also forecasts a non-GAAP EPS of $0.12, indicating anticipated profitability despite the 'Sell' rating.

Institutional sentiment appears notably positive, with 81 funds reporting positions, marking a 1.25% increase in owners last quarter. The average portfolio weight dedicated to SLFPF rose by 16.36%, and total institutional shares increased by 0.42% to 147,632K, with major holders like Vanguard and iShares significantly boosting their allocations.

Key Decisions for Investors

• Investors should carefully evaluate the discrepancy between UBS's 'Sell' rating and the consensus analyst price target suggesting a 39.07% upside, considering the underlying assumptions for each.
• Given the projected 17.29% revenue growth and positive institutional accumulation, assess if the current valuation adequately reflects these fundamental improvements and strong ownership trends.
• Monitor future analyst revisions and company performance against its $1,560MM revenue and $0.12 non-GAAP EPS projections to reconcile the conflicting signals.